Does TRALOKINUMAB-LDRM Cause Ocular hyperaemia? 105 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Ocular hyperaemia have been filed in association with TRALOKINUMAB-LDRM. This represents 2.6% of all adverse event reports for TRALOKINUMAB-LDRM.
105
Reports of Ocular hyperaemia with TRALOKINUMAB-LDRM
2.6%
of all TRALOKINUMAB-LDRM reports
0
Deaths
0
Hospitalizations
How Dangerous Is Ocular hyperaemia From TRALOKINUMAB-LDRM?
Of the 105 reports.
Is Ocular hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRALOKINUMAB-LDRM. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does TRALOKINUMAB-LDRM Cause?
Dermatitis atopic (613)
Drug ineffective (461)
Pruritus (365)
Rash (266)
Injection site pain (206)
Injection site erythema (136)
Dry skin (135)
Erythema (133)
Eczema (129)
Injection site pruritus (124)
What Other Drugs Cause Ocular hyperaemia?
DUPILUMAB (6,938)
CYCLOSPORINE (1,508)
BIMATOPROST (1,447)
CENEGERMIN-BKBJ (1,226)
BRIMONIDINE (917)
ADALIMUMAB (714)
LATANOPROST (587)
DORZOLAMIDE\TIMOLOL (581)
LIFITEGRAST (570)
TRAVOPROST (478)
Which TRALOKINUMAB-LDRM Alternatives Have Lower Ocular hyperaemia Risk?
TRALOKINUMAB-LDRM vs TRAMADOL
TRALOKINUMAB-LDRM vs TRAMADOL\TRAMADOL
TRALOKINUMAB-LDRM vs TRAMETINIB
TRALOKINUMAB-LDRM vs TRAMETINIB DIMETHYL SULFOXIDE
TRALOKINUMAB-LDRM vs TRANDOLAPRIL